Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) study group
Pinch firmly enough to lift the tissue but not so hard that you cause pain from the pinch itself
We were unable to record the average length of time each drug was prescribed for, but more than half of each cohort were still on SGLT2i and GLP-1 RA therapy 3 years post initiation
Scientific Data: In the OASIS 4 trial, 74% of participants experienced at least one gastrointestinal side effect
CDI Query Templates All CDI query templates below are compliant with ACDIS and AHIMA standards: non-leading, multiple-choice format, with clinically neutral phrasing
Why Titration Length Affects the Outcome Numbers Because retatrutide patients spend 24 weeks reaching maintenance dose while Saxenda patients spend 5 weeks, any per-protocol weight-loss comparison at, say, week 12 will underestimate retatrutide's ceiling effect